Emulation of the EMPEROR-Preserved Trial Using Healthcare Claims Data
Completed
Conditions studied: Heart Failure With Preserved Ejection Fraction, Chronic Heart Failure, Type 2 Diabetes Mellitus
In brief
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Key facts
- Study ID
- NCT07599293
- Run by
- Brigham and Women's Hospital
- People needed
- 39614
- Starts
- 2024-10-13
- Expected to finish
- 2026-06-19
- Last updated by the study team
- 2026-07-09
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- At least 18 years of age
- Heart failure with preserved ejection fraction
- Structural heart disease
- Previous HHF
- BMI < 45 kg/m2
- Type 2 diabetes mellitus
- Use of oral diuretics
You may not qualify if…
- Concurrent use of both study drugs on cohort entry date
- MI, CABG or other major cardiovascular surgery, GI surgery or disorder, stroke or TIA
- Implantable cardiac defibrillator
- Hypotension
- Major surgery
- GI surgery or disorder
- Cancer
- Heart transplant
- Pacemaker
- Liver disease
- Atrial fibrillation
- Hypertension
- Impaired renal function
- Anemia
- History of ketoacidosis
- Pregnancy
- Cardiomyopathy
- Valvular heart disease
- Chronic pulmonary disease
- Combined comorbidity score
- Chronic alcohol and or drug abuse
- Noncompliance
- Acute decompensated HF
- Use of SGLT2i or DPP4i
Where it is running
- Brigham and Women's Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.